Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the epidemiology of opioid-related harm in the US, with focus on adolescents and young adults.
2. Prescribe opioids in a manner that reduces the likelihood of risk for long-term opioid use and addiction.
3. Demonstrate evidence-based screening and treatment for youth with opioid use disorder.

Faculty

Scott Hadland, MD
Assistant Professor of Pediatrics
Boston University School of Medicine

 

Faculty Disclosure

Shannon Kay, PH.D., BCBA-D is a stock shareholder in Allergan, Pfizer, Glaxosmithklein, Merck, Gilead.

 

Session date: 
Tuesday, October 22, 2019 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours
  • 1.00 APA Psychologists American Psychological Association
    Baystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
  • 1.00 BCIPE Risk Management

Please login or register to take this course.